TABLE 1.
Organism (no. of strains) | Compound | MIC (μg/ml) |
% Susceptiblea | ||
---|---|---|---|---|---|
Range | 50% | 90% | |||
MSSA (25) | BAL0030543 | 0.015-0.06 | 0.03 | 0.03 | 100 |
BAL0030544 | 0.015-0.25 | 0.03 | 0.03 | 100 | |
BAL0030545 | 0.015-0.25 | 0.12 | 0.25 | 100 | |
Trimethoprim | 0.25-32 | 1 | 2 | 92 | |
Daptomycin | 0.12-0.25 | 0.25 | 0.25 | 100 | |
Linezolid | 2-2 | 2 | 2 | 100 | |
Minocycline | 0.25-0.25 | 0.25 | 0.25 | 100 | |
Moxifloxacin | 0.12-4 | 0.12 | 0.25 | 92 | |
Vancomycin | 0.5-1 | 1 | 1 | 100 | |
MRSA (25) | BAL0030543 | 0.015-0.06 | 0.015 | 0.06 | 100 |
BAL0030544 | 0.03-0.25 | 0.06 | 0.25 | 100 | |
BAL0030545 | 0.06-0.06 | 0.06 | 0.06 | 100 | |
Trimethoprim | 0.12-0.25 | 0.25 | 32 | 80 | |
Daptomycin | 0.12-0.25 | 0.12 | 0.25 | 100 | |
Linezolid | 2-2 | 2 | 2 | 100 | |
Minocycline | 0.25-0.25 | 0.25 | 0.25 | 100 | |
Moxifloxacin | 0.12-4 | 4 | 8 | 4 | |
Vancomycin | 0.5-1 | 1 | 1 | 100 | |
hVISA (25) | BAL0030543 | 0.015-0.06 | 0.03 | 0.06 | 100 |
BAL0030544 | 0.03-0.25 | 0.25 | 0.25 | 100 | |
BAL0030545 | 0.03-0.06 | 0.06 | 0.06 | 100 | |
Trimethoprim | 0.06-32 | 1 | 16 | 80 | |
Daptomycin | 0.25-2 | 0.5 | 0.5 | 96 | |
Linezolid | 1-1 | 1 | 2 | 100 | |
Minocycline | 0.12-8 | 0.25 | 0.5 | 92 | |
Moxifloxacin | 0.12-4 | 4 | 4 | 8 | |
Vancomycin | 1-4 | 1 | 2 | 96 | |
VISA (17) | BAL0030543 | 0.015-0.5 | 0.003 | 0.25 | 100 |
BAL0030544 | 0.03-0.5 | 0.25 | 0.5 | 100 | |
BAL0030545 | 0.06-8 | 0.06 | 0.5 | 100 | |
Trimethoprim | 0.12-32 | 1 | 32 | 71 | |
Daptomycin | 0.25-2 | 1 | 2 | 71 | |
Linezolid | 0.5-2 | 1 | 2 | 100 | |
Minocycline | 0.12-8 | 1 | 4 | 96 | |
Moxifloxacin | 8-8 | 8 | 8 | 0 | |
Vancomycin | 1-4 | 2 | 4 | 52 | |
Coagulase-negative | BAL0030543 | 0.015-16 | 0.06 | 8 | 86 |
staphylococci (29) | BAL0030544 | 0.03-32 | 0.06 | 8 | 86 |
BAL0030545 | 0.03-16 | 0.06 | 4 | 86 | |
Trimethoprim | 0.12-32 | 16 | 32 | 48 | |
Daptomycin | 0.06-0.5 | 0.25 | 0.5 | 100 | |
Linezolid | 0.25-2 | 1 | 2 | 100 | |
Minocycline | 0.25-8 | 0.5 | 2 | 96 | |
Moxifloxacin | 0.12-8 | 0.25 | 8 | 55 | |
Vancomycin | 0.5-4 | 1 | 2 | 100 | |
Group A streptococci (17) | BAL0030543 | 0.015-0.06 | 0.06 | 0.06 | 100 |
BAL0030544 | 0.06-0.06 | 0.06 | 0.06 | 100 | |
BAL0030545 | 0.03-0.12 | 0.06 | 0.12 | 100 | |
Trimethoprim | 0.12-0.5 | 0.5 | 1 | N/A | |
Daptomycin | 0.015-0.03 | 0.015 | 0.03 | 100 | |
Linezolid | 0.5-1 | 1 | 1 | 100 | |
Minocycline | 0.12-0.25 | 0.12 | 0.25 | 100 | |
Moxifloxacin | 0.25-0.5 | 0.25 | 0.5 | N/A | |
Vancomycin | 0.12-0.25 | 0.25 | 0.25 | 100 | |
Group B streptococci (17) | BAL0030543 | 0.015-0.06 | 0.03 | 0.06 | 100 |
BAL0030544 | 0.06-0.12 | 0.06 | 0.12 | 100 | |
BAL0030545 | 0.06-0.12 | 0.06 | 0.12 | 100 | |
Trimethoprim | 0.25-2 | 1 | 1 | N/A | |
Daptomycin | 0.015-0.06 | 0.015 | 0.06 | 100 | |
Linezolid | 1-2 | 1 | 2 | 100 | |
Minocycline | 0.12-32 | 16 | 32 | 29 | |
Moxifloxacin | 0.25-0.5 | 0.25 | 0.5 | N/A | |
Vancomycin | 0.12-0.25 | 0.25 | 0.25 | 100 | |
Group C streptococci (13) | BAL0030543 | <0.008-0.12 | 0.015 | 0.06 | 100 |
BAL0030544 | <0.008-0.25 | 0.06 | 0.06 | 100 | |
BAL0030545 | 0.03-0.25 | 0.06 | 0.12 | 100 | |
Trimethoprim | <0.008-8 | 0.5 | 1 | N/A | |
Daptomycin | 0.015-0.12 | 0.03 | 0.12 | 100 | |
Linezolid | 1-1 | 1 | 2 | 100 | |
Minocycline | 0.12-16 | 0.25 | 4 | 84 | |
Moxifloxacin | 0.25-0.5 | 0.25 | 0.5 | N/A | |
Vancomycin | 0.12-0.5 | 0.12 | 0.5 | 100 | |
Group G streptococci (12) | BAL0030543 | 0.015-0.06 | 0.03 | 0.06 | 100 |
BAL0030544 | 0.06-0.25 | 0.06 | 0.06 | 100 | |
BAL0030545 | 0.03-0.12 | 0.03 | 0.06 | 100 | |
Trimethoprim | 0.5-1 | 1 | 1 | N/A | |
Daptomycin | 0.015-0.03 | 0.015 | 0.03 | 100 | |
Linezolid | 1-2 | 2 | 2 | 100 | |
Minocycline | 0.12-16 | 0.25 | 16 | 75 | |
Moxifloxacin | 0.25-4 | 0.25 | 0.5 | N/A | |
Vancomycin | 0.12-0.25 | 0.12 | 0.12 | 100 | |
Streptococcus pneumoniae (15) | BAL0030543 | 0.015-0.12 | 0.06 | 0.12 | 100 |
BAL0030544 | 0.03-0.25 | 0.12 | 0.25 | 100 | |
BAL0030545 | 0.03-0.25 | 0.12 | 0.12 | 100 | |
Trimethoprim | 0.5-8 | 1 | 4 | N/A | |
Daptomycin | <0.008-0.5 | 0.06 | 0.12 | N/A | |
Linezolid | 0.03-2 | 1 | 2 | 100 | |
Minocycline | 0.12-8 | 0.25 | 0.25 | 93 | |
Moxifloxacin | 0.12-0.5 | 0.25 | 0.25 | 100 | |
Vancomycin | 0.06-0.5 | 0.12 | 0.25 | 100 | |
Corynebacterium spp. (12) | BAL0030543 | <0.008-8 | 0.06 | 4 | 83 |
BAL0030544 | 0.015-16 | 0.12 | 4 | 83 | |
BAL0030545 | <0.008-6 | 0.12 | 4 | 83 | |
Trimethoprim | 0.12-16 | 16 | 16 | N/A | |
Daptomycin | 0.03-0.12 | 0.06 | 0.12 | N/A | |
Linezolid | 0.12-1 | 0.06 | 0.12 | N/A | |
Minocycline | 0.06-32 | 2 | 16 | N/A | |
Moxifloxacin | 0.25-16 | 1 | 8 | N/A | |
Vancomycin | 0.12-0.5 | 0.25 | 0.5 | N/A | |
Listeria monocytogenes (10) | BAL30543 | 0.015-0.015 | 0.015 | 0.015 | 100 |
BAL30544 | 0.03-0.03 | 0.03 | 0.03 | 100 | |
BAL30545 | 0.06-0.06 | 0.06 | 0.06 | 100 | |
Trimethoprim | 0.06-0.06 | 0.06 | 0.06 | N/A | |
Daptomycin | 0.5-2 | 1 | 2 | N/A | |
Linezolid | 2-2 | 2 | 2 | N/A | |
Minocycline | 0.25-16 | 0.25 | 16 | N/A | |
Moxifloxacin | 0.5-1 | 0.5 | 1 | N/A | |
Vancomycin | 1-1 | 1 | 1 | N/A | |
Streptococcus mitis (8) | BAL0030543 | <0.008-0.06 | <0.008 | 100 | |
BAL0030544 | <0.008-0.06 | 0.03 | 100 | ||
BAL0030545 | <0.008-0.12 | 0.015 | 100 | ||
Trimethoprim | <0.008-8 | 4 | |||
Daptomycin | 0.006-0.5 | 0.25 | |||
Linezolid | <0.008-1 | 1 | |||
Minocycline | 0.25-8 | 0.25 | |||
Moxifloxacin | 0.12-1 | 0.25 | |||
Vancomycin | <0.008-1 | 1 |
N/A, breakpoint not available. A breakpoint of 0.5 mg/liter was used for BAL compounds for comparison.